CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

The Global Women’s Health Market is expected to witness a growth rate of 4-5% in the next five years. Growing incidence of ...

The Global Life Science Consulting Services Market is expected to witness a growth rate of 10% in the next five ...

The Personal Mobility Devices Market is poised for steady growth, with an anticipated expansion rate of around 7% during the ...

The Global Single-use Bioreactors Market is set to witness a healthy growth rate of 20% by 2029. Technological innovations ...

The Liposomal Doxorubicin Market is estimated to be valued at USD 1,281.3 million in 2024. Demand is predicted to rise at a ...

The Global Medical Devices Outsourcing market is expanding at a healthy growth rate of 13% due to the increasing tendency of ...

The global sales of DNA diagnostics are estimated to be worth USD 27,094.2 million in 2024 and are anticipated to reach a ...

Groundbreaking procedures extend ONWARD’s leadership in the rapidly emerging brain-computer interface (BCI) fieldARC-BCI ...

The Global Nanomedicine Market is expected to witness a growth rate of 10-12% in the next five years. Ongoing research and ...

SEATTLE, WASHINGTON / ACCESS Newswire / May 21, 2025 / MD Clarity, a leading provider of revenue optimization software, today announced the launch of a major expansion of its denial management module.